Pavan Cheruvu M.D.
Net Worth
Last updated:
What is Pavan Cheruvu M.D. net worth?
The estimated net worth of Dr. Pavan Cheruvu M.D. is at least $5,083,515 as of 23 Mar 2021. He owns shares worth $74,895 as insider and has received compensation worth at least $5,008,620 in Sio Gene Therapies Inc..
What is the salary of Pavan Cheruvu M.D.?
Dr. Pavan Cheruvu M.D. salary is $834,770 per year as Chief Executive Officer, Pres & Director in Sio Gene Therapies Inc..
How old is Pavan Cheruvu M.D.?
Dr. Pavan Cheruvu M.D. is 43 years old, born in 1982.
What stocks does Pavan Cheruvu M.D. currently own?
As insider, Dr. Pavan Cheruvu M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sio Gene Therapies Inc. (SIOX) | Chief Executive Officer, Pres & Director | 180,426 | $0.42 | $74,895 |
What does Sio Gene Therapies Inc. do?
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
Pavan Cheruvu M.D. insider trading
Sio Gene Therapies key executives
Sio Gene Therapies Inc. executives and other stock owners filed with the SEC:
- Dr. Pavan Cheruvu M.D. (43) Chief Executive Officer, Pres & Director
- Mr. David W. Nassif (71) Chief Financial Officer, Chief Accounting Officer & Gen. Counsel